OKYO Pharma to Ring the Opening Bell at Nasdaq

OKYO Pharma to Ring the Opening Bell at Nasdaq GlobeNewswire December 19, 2025 LONDON and NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without […]

Safe & Green Holdings Completes Strategic Acquisition of Giant Containers

Safe & Green Holdings Completes Strategic Acquisition of Giant Containers GlobeNewswire December 19, 2025 Conroe, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) — CONROE, Texas, Dec 19, 2025 (GLOBE NEWSWIRE) — via IBN – Safe & Green Holdings Corp. (NASDAQ: SGBX) (“Safe & Green” or the “Company”), announced that it has successfully closed the acquisition of

NFI Group Amends Agreement with Coliseum Capital Management

NFI Group Amends Agreement with Coliseum Capital Management GlobeNewswire December 19, 2025 Provides Coliseum flexibility to increase its ownership up to 25% of NFI's outstanding shares Reflects long-term support and confidence of NFI's largest shareholder WINNIPEG. Manitoba, Dec. 19, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (“NFI” or the

Malibu Boats Inc. Expands Share Repurchase Program to $70 Million

Malibu Boats Inc. Expands Share Repurchase Program to $70 Million Capital allocation strategy aims to combine investing in core business and returning excess capital to shareholders GlobeNewswire December 19, 2025 LOUDON, Tenn., Dec. 19, 2025 (GLOBE NEWSWIRE) — Malibu Boats, Inc. (Nasdaq: MBUU), a U.S. designer and manufacturer of category-leading salt and freshwater recreational powerboat

Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2025

Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2025 GlobeNewswire December 19, 2025 CHICAGO, Dec. 19, 2025 (GLOBE NEWSWIRE) — Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a commercial mortgage real estate investment trust, announced that its board of directors has declared a regular quarterly cash

Winnebago Industries Reports First Quarter Fiscal 2026 Results

Winnebago Industries Reports First Quarter Fiscal 2026 Results GlobeNewswire December 19, 2025 — Quarterly Net Revenues Increase 12.3%, Driven by Growth in Motorhome and Towable RV Segments — — Improved Top-Line Performance and Cost Discipline Deliver Margin Gains and Strengthen Balance Sheet — — Barletta Continues Share Expansion in U.S. Aluminum Pontoon Segment(1) — —

Whitestone REIT Grows Dividend 5.6%

Whitestone REIT Grows Dividend 5.6% GlobeNewswire December 19, 2025 Board of Trustees Authorizes $50 Million Share Repurchase Program Company Announces Transition to Quarterly Dividend Payments HOUSTON, Dec. 19, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that its Board of Trustees has declared a quarterly cash dividend of $0.1425

Cheer Holding Announces Share Consolidation of Class A Ordinary Shares

Cheer Holding Announces Share Consolidation of Class A Ordinary Shares GlobeNewswire December 19, 2025 Class A Ordinary Shares Will Begin Trading on a Post-Consolidation Adjusted Basis onDecember 23, 2025 BEIJING, Dec. 19, 2025 (GLOBE NEWSWIRE) — Cheer Holding, Inc. (NASDAQ: CHR) (“Cheer Holding,” “we” or the “Company”), a leading provider of next-generation mobile internet infrastructure

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 19, 2025 FRIENDSWOOD, Texas, Dec. 19, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on Dec. 15, 2025, the Compensation Committee of its Board of Directors granted restricted

Evaxion provides update on MSD collaboration – retains global rights to Gonorrhea vaccine candidate EVX-B2

Evaxion provides update on MSD collaboration – retains global rights to Gonorrhea vaccine candidate EVX-B2 GlobeNewswire December 19, 2025 MSD declines to exercise option for EVX-B2 development Evaxion is now able to out-license EVX-B2 to another partner Evaxion maintains its strong belief in EVX-B2, which has shown to be protective against Gonorrhea in preclinical studies

Scroll to Top